OBJECTIVE: To systematically review the available literature on measuring pain and the efficacy of pain treatment in inflammatory arthritis (IA), as an evidence base for generating clinical practice recommendations. METHODS: A systematic literature search was performed in Medline, Embase, Cochrane Library, and the American College of Rheumatology/European League Against Rheumatism 2008/2009 meeting abstracts, searching for studies evaluating clinimetric properties of pain measurement tools in IA (convergent validity, internal consistency, retest reliability, responsiveness, feasibility, and standardization). Studies that presented information on these properties were reviewed and their data were integrated into the pool of results available for pain measures in IA. RESULTS: In total, 51 articles were included in the review. Validated information on pain was available for tools covering different facets such as overall pain, anatomically specific pain, or a mixture of both. Data from these studies showed that single pain-related items such as the visual analog scale (VAS), numeric rating scale (NRS), or verbal rating scale (VRS) provide sufficient clinimetric information. Similar results were obtained for the pain subscales of the Arthritis Impact Measurement Scales (AIMS/AIMS2) and the bodily pain subscale of the Medical Outcome Study Short-Form Survey 36. Most clinimetric coefficients showed acceptable results with respect to validity, reliability, and sensitivity to change, while the degree of standardization and feasibility mostly filled at least 2 of 3 predefined criteria. CONCLUSION: A variety of pain measures are available to cover different aspects of pain such as intensity, frequency, or location. Single-item tools such as VAS, NRS, or VRS can be recommended to measure overall pain in clinical practice. If more specific issues need to be addressed, more sophisticated tools should be taken into account.
OBJECTIVE: To systematically review the available literature on measuring pain and the efficacy of pain treatment in inflammatory arthritis (IA), as an evidence base for generating clinical practice recommendations. METHODS: A systematic literature search was performed in Medline, Embase, Cochrane Library, and the American College of Rheumatology/European League Against Rheumatism 2008/2009 meeting abstracts, searching for studies evaluating clinimetric properties of pain measurement tools in IA (convergent validity, internal consistency, retest reliability, responsiveness, feasibility, and standardization). Studies that presented information on these properties were reviewed and their data were integrated into the pool of results available for pain measures in IA. RESULTS: In total, 51 articles were included in the review. Validated information on pain was available for tools covering different facets such as overall pain, anatomically specific pain, or a mixture of both. Data from these studies showed that single pain-related items such as the visual analog scale (VAS), numeric rating scale (NRS), or verbal rating scale (VRS) provide sufficient clinimetric information. Similar results were obtained for the pain subscales of the Arthritis Impact Measurement Scales (AIMS/AIMS2) and the bodily pain subscale of the Medical Outcome Study Short-Form Survey 36. Most clinimetric coefficients showed acceptable results with respect to validity, reliability, and sensitivity to change, while the degree of standardization and feasibility mostly filled at least 2 of 3 predefined criteria. CONCLUSION: A variety of pain measures are available to cover different aspects of pain such as intensity, frequency, or location. Single-item tools such as VAS, NRS, or VRS can be recommended to measure overall pain in clinical practice. If more specific issues need to be addressed, more sophisticated tools should be taken into account.
Authors: Ivan Delgado-Enciso; Brenda Paz-Michel; Valery Melnikov; Jose Guzman-Esquivel; Francisco Espinoza-Gomez; Alejandro D Soriano-Hernandez; Iram P Rodriguez-Sanchez; Margarita L Martinez-Fierro; Gabriel Ceja-Espiritu; Bertha A Olmedo-Buenrostro; Hector R Galvan-Salazar; Osiris G Delgado-Enciso; Josuel Delgado-Enciso; Uriel A Lopez-Lemus; Daniel A Montes-Galindo Journal: Exp Ther Med Date: 2017-12-21 Impact factor: 2.447
Authors: Samuel L Whittle; Alexandra N Colebatch; Rachelle Buchbinder; Christopher J Edwards; Karen Adams; Matthias Englbrecht; Glen Hazlewood; Jonathan L Marks; Helga Radner; Sofia Ramiro; Bethan L Richards; Ingo H Tarner; Daniel Aletaha; Claire Bombardier; Robert B Landewé; Ulf Müller-Ladner; Johannes W J Bijlsma; Jaime C Branco; Vivian P Bykerk; Geraldo da Rocha Castelar Pinheiro; Anca I Catrina; Pekka Hannonen; Patrick Kiely; Burkhard Leeb; Elisabeth Lie; Píndaro Martinez-Osuna; Carlomaurizio Montecucco; Mikkel Ostergaard; Rene Westhovens; Jane Zochling; Désirée van der Heijde Journal: Rheumatology (Oxford) Date: 2012-03-24 Impact factor: 7.580
Authors: Eva M Sobas; Roberto Reinoso; Rubén Cuadrado-Asensio; Itziar Fernández; Miguel J Maldonado; José C Pastor Journal: PLoS One Date: 2016-12-01 Impact factor: 3.240
Authors: Ruud A Leijendekkers; J Bart Staal; Gerben van Hinte; Jan Paul Frölke; Hendrik van de Meent; Femke Atsma; Maria W G Nijhuis-van der Sanden; Thomas J Hoogeboom Journal: BMC Musculoskelet Disord Date: 2016-11-22 Impact factor: 2.362
Authors: L Bellido-Fernández; J J Jiménez-Rejano; R Chillón-Martínez; M A Gómez-Benítez; M De-La-Casa-Almeida; M Rebollo-Salas Journal: Evid Based Complement Alternat Med Date: 2018-02-22 Impact factor: 2.629
Authors: Ivan Delgado-Enciso; Juan Paz-Garcia; Carlos E Barajas-Saucedo; Karen A Mokay-Ramírez; Carmen Meza-Robles; Rodrigo Lopez-Flores; Marina Delgado-Machuca; Efren Murillo-Zamora; Jose A Toscano-Velazquez; Josuel Delgado-Enciso; Valery Melnikov; Mireya Walle-Guillen; Hector R Galvan-Salazar; Osiris G Delgado-Enciso; Ariana Cabrera-Licona; Eduardo J Danielewicz-Mata; Pablo J Mandujano-Diaz; José Guzman-Esquivel; Daniel A Montes-Galindo; Henry Perez-Martinez; Jesus M Jimenez-Villegaz; Alejandra E Hernandez-Rangel; Patricia Montes-Diaz; Iram P Rodriguez-Sanchez; Margarita L Martinez-Fierro; Idalia Garza-Veloz; Daniel Tiburcio-Jimenez; Sergio A Zaizar-Fregoso; Fidadelfo Gonzalez-Alcaraz; Laydi Gutierrez-Gutierrez; Luciano Diaz-Lopez; Mario Ramirez-Flores; Hannah P Guzman-Solorzano; Gustavo Gaytan-Sandoval; Carlos R Martinez-Perez; Francisco Espinoza-Gómez; Fabián Rojas-Larios; Michael J Hirsch-Meillon; Luz M Baltazar-Rodriguez; Enrique Barrios-Navarro; Vladimir Oviedo-Rodriguez; Martha A Mendoza-Hernandez; Emilio Prieto-Diaz-Chavez; Brenda A Paz-Michel Journal: Exp Ther Med Date: 2021-06-29 Impact factor: 2.447